A61K 39/015
Hemosporidia antigens
Official title: Hemosporidia antigens, e.g. Plasmodium antigens
A61K39/015 (Hemosporidia antigens) appears on 442 US grants and 673 published applications in this corpus.
Search patents in A61K- Granted patents
- 442
- Published applications
- 673
- Assignees
- 341
- Inventors
- 1,178
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 4 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 0 |
| 2002 | 1 | 14 |
| 2003 | 7 | 21 |
| 2004 | 3 | 16 |
| 2005 | 7 | 23 |
| 2006 | 8 | 21 |
| 2007 | 11 | 13 |
| 2008 | 13 | 27 |
| 2009 | 11 | 22 |
| 2010 | 12 | 36 |
| 2011 | 10 | 27 |
| 2012 | 18 | 40 |
| 2013 | 19 | 33 |
| 2014 | 18 | 23 |
| 2015 | 25 | 29 |
| 2016 | 26 | 37 |
| 2017 | 33 | 37 |
| 2018 | 26 | 30 |
| 2019 | 27 | 31 |
| 2020 | 19 | 36 |
| 2021 | 25 | 35 |
| 2022 | 22 | 29 |
| 2023 | 18 | 23 |
| 2024 | 18 | 32 |
| 2025 | 19 | 20 |
| 2026 | 7 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anti-parasitic immunological compositions9 Jun 2026US 12,648,993 B2Board of Regents of the University of Nebraska
- Transmission-blocking vaccine against Babesia26 May 2026US 12,636,355 B2James Cook University
- Modified virus-like particles of CMV21 Apr 2026US 12,605,454 B2Saiba GmbH
- Compositions comprising CelTOS immunogens and antibodies and method of use thereof10 Feb 2026US 12,544,441 B2University of South Florida
- Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases27 Jan 2026US 12,533,404 B2Centre National De La Recherche Scientifique
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Compositions for delivery of liver stage antigens and related methods3 Sep 2026US 2026/0256898 A1BioNTech SE
- Malaria immunogen and methods for using same27 Aug 2026US 2026/0248900 A1The Johns Hopkins University
- Oral vaccine20 Aug 2026US 2026/0240985 A1WestfäLische Wilhelms-UniversitäT MüNster
Most cited
By later US patents
- Hybrid particle immunogens118US 4,722,840 AChiron Corporation · 1988
- Zika virus RNA vaccines108US 10,124,055 B2ModernaTX, Inc. · 2018
- Vaccines102US 6,544,518 B1SmithKline Beecham Biologicals s.a. · 2003
- Adjuvant systems and vaccines92US 7,357,936 B1SmithKline Beecham Biologicals s.a. · 2008
- Vaccine compositions containing liposomes86US 5,709,879 AChiron Corporation · 1998